# Tolerance and Performance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots

> **NCT05600049** · NA · COMPLETED · sponsor: **Cryonove Pharma** · enrollment: 33 (actual)

## Conditions studied

- Lentigo Solar

## Interventions

- **DEVICE:** Prototypes (815-v1 001) to (815-v1 050)
- **DEVICE:** Prototype (815-v1 051) to (815-v1 100)
- **DEVICE:** Prototypes (815-v1 101) to (815-v1 150)
- **DEVICE:** Prototypes (815-v1 151) to (815-v1 200)

## Key facts

- **NCT ID:** NCT05600049
- **Lead sponsor:** Cryonove Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-21
- **Primary completion:** 2023-06-08
- **Final completion:** 2023-06-08
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2023-06-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05600049

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05600049, "Tolerance and Performance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05600049. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*